NYSE • Healthcare • Medical - Devices • US • USD
Boston Scientific Corporation (BSX-PA) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 12 recommend buying, 1 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
